PMO Interview with the Innovator Series: Volume 5
Michael Pellini, MD
Video Categories: PMO Interview with the Innovator Series
Michael Pellini, President and Chief Executive Officer of Foundation Medicine, offers a definition of personalized medicine in this new video series from Personalized Medicine in Oncology.
According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical [ Read More ]
Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.